“I didn’t know women could have haemophilia”: A qualitative case study

1 Callaghan MU, Kaufman RJ. Cellular processing of factor VIII and factor IX. In: Lee C, Berntorp E, Hoots K, eds. Textbook of Haemophilia, 2nd edn. 2010. Oxford, UK: Wiley-Blackwell. CallaghanMU KaufmanRJ Cellular processing of factor VIII and factor IX In: LeeC BerntorpE HootsK eds. Textbook of Haemophilia 2nd edn. 2010 Oxford, UK Wiley-Blackwell 10.1002/9781444318555.ch2 Search in Google Scholar

2 Kitchen S, de Paula Cereta F, de Lima Montalvão SA, et al. Laboratory diagnosis and monitoring. WFH Guidelines for the Management of Hemophilia, 3rd edition. Haemophilia 2020; 26(S6): 35–48. doi: 10.1111/hae.14046. KitchenS de Paula CeretaF de Lima MontalvãoSA Laboratory diagnosis and monitoring. WFH Guidelines for the Management of Hemophilia, 3rd edition Haemophilia 2020 26 S6 35 48 10.1111/hae.14046 32744769 Open DOISearch in Google Scholar

3 Hatton C, Hay D, Keeling DM. Haemostasis, abnormal bleeding and anticoagulant therapy. In: Hatton C, Hay D, Keeling DM, eds. Haematology: Lecture Notes, 10th edn. 2018. Chichester, UK: Wiley-Blackwell. HattonC HayD KeelingDM Haemostasis, abnormal bleeding and anticoagulant therapy In: HattonC HayD KeelingDM eds. Haematology: Lecture Notes 10th edn. 2018 Chichester, UK Wiley-Blackwell Search in Google Scholar

4 Stonebraker JS, Bolton-Maggs PHB, Brooker M, et al. The World Federation of Hemophilia Annual Global Survey 1999–2018. Haemophilia 2020; 27: 591–600. doi: 10.1111/hae.14012. StonebrakerJS Bolton-MaggsPHB BrookerM The World Federation of Hemophilia Annual Global Survey 1999–2018 Haemophilia 2020 27 591 600 10.1111/hae.14012 32497379 Open DOISearch in Google Scholar

5 Iorio A, Stonebraker JS, Chambost H, Makris M, Coffin D, Herr C. Establishing the male prevalence and prevalence at birth of hemophilia: A meta-analytic approach using national registries. Ann Intern Med 2019; 171(8): 540–546]. doi: 10.7326/M19-1208. IorioA StonebrakerJS ChambostH MakrisM CoffinD HerrC Establishing the male prevalence and prevalence at birth of hemophilia: A meta-analytic approach using national registries Ann Intern Med 2019 171 8 540 546 10.7326/M19-1208 31499529 Open DOISearch in Google Scholar

6 Pipe SW, Carcao M, Chew K, et al. Hemostatic agents. WFH Guidelines for the Management of Hemophilia, 3rd edition. Haemophilia 2020; 26(S6): 59–71. doi: 10.1111/hae.14046. PipeSW CarcaoM ChewK Hemostatic agents. WFH Guidelines for the Management of Hemophilia, 3rd edition Haemophilia 2020 26 S6 59 71 10.1111/hae.14046 Open DOISearch in Google Scholar

7 Francini M, Mannucci M. Non-factor replacement therapy for haemophilia: a current update. Blood Transfus 2018; 16: 457–61. doi: 10.2450/2018.0272-17. FranciniM MannucciM Non-factor replacement therapy for haemophilia: a current update Blood Transfus 2018 16 457 61 10.2450/2018.0272-17 612523029517971 Open DOISearch in Google Scholar

8 Garrison LP, Kleinermans D. Is the world ready for gene therapy? Haemophilia 2022; 28(Supp 2): 5–8. doi: 10.1111/hae.14439. GarrisonLP KleinermansD Is the world ready for gene therapy? Haemophilia 2022 28 Supp 2 5 8 10.1111/hae.14439 35318781 Open DOISearch in Google Scholar

9 DeKoven M, Karkare S, Lee WC, et al. Impact of haemophilia with inhibitors on caregiver burden in the United States. Haemophilia 2014; 20: 822–830. doi: 10.1111/hae.12501. DeKovenM KarkareS LeeWC Impact of haemophilia with inhibitors on caregiver burden in the United States Haemophilia 2014 20 822 830 10.1111/hae.12501 25273645 Open DOISearch in Google Scholar

10 Khair K, Kulkowska A, Myrin Westersson L, et al. The burden of bleeds and other clinical determinants on caregivers of children with haemophilia (the BBC Study). Haemophilia 2019; 25: 416–423. doi: 10.1111/hae.13736. KhairK KulkowskaA Myrin WesterssonL The burden of bleeds and other clinical determinants on caregivers of children with haemophilia (the BBC Study) Haemophilia 2019 25 416 423 10.1111/hae.13736 30925018 Open DOISearch in Google Scholar

11 Miller CH, Bean CJ. Genetic causes of haemophilia in women and girls. Haemophilia 2021; 27: e164–e179. doi: 10.1111/hae.14186. MillerCH BeanCJ Genetic causes of haemophilia in women and girls Haemophilia 2021 27 e164 e179 10.1111/hae.14186 813247433314404 Open DOISearch in Google Scholar

12 Shoukat HMH, Ghulam Ghous G, Tarar ZI, Shoukat MM, Ajma N. Skewed inactivation of X chromosome: a cause of hemophilia manifestation in carrier females. Cureus 2020; 12(10):e11216. doi: 10.7759/cureus.11216. ShoukatHMH Ghulam GhousG TararZI ShoukatMM AjmaN Skewed inactivation of X chromosome: a cause of hemophilia manifestation in carrier females Cureus 2020 12 10 e11216 10.7759/cureus.11216 770415633269146 Open DOISearch in Google Scholar

13 Kasper CK, Lin JC. How many carriers are there? Haemophilia 2010; 16(5): 842. doi: 10.1111/j.1365-2516.2010.02210.x KasperCK LinJC How many carriers are there? Haemophilia 2010 16 5 842 10.1111/j.1365-2516.2010.02210.x 20148976 Open DOISearch in Google Scholar

14 van Galen K, Lavin M, Skouw-Rasmussen N, et al.; European Haemophilia Consortium (EHC), European Association for Haemophilia and Allied Disorders (EAHAD). European principles of care for women and girls with inherited bleeding disorders. Haemophilia 2021; 27(5): 837–847. doi: 10.1111/hae.14379. van GalenK LavinM Skouw-RasmussenN European Haemophilia Consortium (EHC), European Association for Haemophilia and Allied Disorders (EAHAD) European principles of care for women and girls with inherited bleeding disorders Haemophilia 2021 27 5 837 847 10.1111/hae.14379 34343384 Open DOISearch in Google Scholar

15 Weyand AC, James PD. Sexism in the management of bleeding disorders. Res Pract Thromb Haemost 2021; 5: 51–54. doi: 10.1002/rth2.12468. WeyandAC JamesPD Sexism in the management of bleeding disorders Res Pract Thromb Haemost 2021 5 51 54 10.1002/rth2.12468 784507033537529 Open DOISearch in Google Scholar

16 Khair K, Steadman L, Chaplin S, et al. Parental perspectives on gene therapy for children with haemophilia: the Exigency study. Haemophilia 2021; 27(1): 120–128. doi: 10.1111/hae.14188. KhairK SteadmanL ChaplinS Parental perspectives on gene therapy for children with haemophilia: the Exigency study Haemophilia 2021 27 1 120 128 10.1111/hae.14188 33216422 Open DOISearch in Google Scholar

17 Fletcher S, Jenner K, Holland M, Chaplin S, Khair K. An exploration of why men with severe haemophilia might not want gene therapy: the Exigency study. Haemophilia 2021; 27(5): 760–768. doi: 10.1111/hae.14378. FletcherS JennerK HollandM ChaplinS KhairK An exploration of why men with severe haemophilia might not want gene therapy: the Exigency study Haemophilia 2021 27 5 760 768 10.1111/hae.14378 34265145 Open DOISearch in Google Scholar

18 Fletcher S, Jenner K, Pembroke L, Holland M, Khair K. The experiences of people with haemophilia, and their families, of gene therapy in a clinical trial setting: regaining control, the Exigency study. Orphanet J Rare Dis 2022; 17: 155. doi: 10.1186/s13023-022-02256-2. FletcherS JennerK PembrokeL HollandM KhairK The experiences of people with haemophilia, and their families, of gene therapy in a clinical trial setting: regaining control, the Exigency study Orphanet J Rare Dis 2022 17 155 10.1186/s13023-022-02256-2 898174735379267 Open DOISearch in Google Scholar

19 Stake RE. The Art of Case Study Research. 1995. London: Sage Publications. StakeRE The Art of Case Study Research 1995 London Sage Publications Search in Google Scholar

20 Schwandt TA, Gates EF. Case study methodology. In Denzin NK, Lincoln YS, eds. The SAGE Handbook of Qualitative Research, 5th edn. 2017. London: Sage Publications. SchwandtTA GatesEF Case study methodology In DenzinNK LincolnYS eds. The SAGE Handbook of Qualitative Research 5th edn. 2017 London Sage Publications Search in Google Scholar

21 Archibald MM, Ambagtsheer RC, Casey MG, Lawless M. Using Zoom videoconferencing for qualitative data collection: perceptions and experiences of researchers and participants. International Journal of Qualitative Methods 2019; 18: 1–8. doi: 10.1177/1609406919874596. ArchibaldMM AmbagtsheerRC CaseyMG LawlessM Using Zoom videoconferencing for qualitative data collection: perceptions and experiences of researchers and participants International Journal of Qualitative Methods 2019 18 1 8 10.1177/1609406919874596 Open DOISearch in Google Scholar

22 S Fletcher. Seeing the bigger picture: Qualitative research in the Zoom^® age. J Haem Pract 2021; 8(1): 141–144. doi: 10.2478/jhp-2021-0019. FletcherS Seeing the bigger picture: Qualitative research in the Zoom^® age J Haem Pract 2021 8 1 141 144 10.2478/jhp-2021-0019 Open DOISearch in Google Scholar

23 Alhojailan MI. Thematic analysis: A critical review of its process and evaluation. West East Journal of Social Sciences 2012; 1(1): 39–47. AlhojailanMI Thematic analysis: A critical review of its process and evaluation West East Journal of Social Sciences 2012 1 1 39 47 Search in Google Scholar

24 NHS Health Research Authority. Is My Study Research? October 2017. Available from http://www.hra-decisiontools.org.uk/research/ (accessed 3 January 2022). NHS Health Research Authority Is My Study Research? October 2017 Available from http://www.hra-decisiontools.org.uk/research/ (accessed 3 January 2022). Search in Google Scholar

25 Denny C, Grady C. Research involving women. In: Emanuel EJ, Grady C, Crouch RA, et al., eds. The Oxford Textbook of Clinical Research Ethics. 2008. Oxford, UK: Oxford University Press. DennyC GradyC Research involving women In: EmanuelEJ GradyC CrouchRA eds. The Oxford Textbook of Clinical Research Ethics 2008 Oxford, UK Oxford University Press 10.1093/oso/9780195168655.003.0039 Search in Google Scholar

26 Steinberg JR, Turner BE, Weeks BT, et al. Analysis of female enrollment and participant sex by burden of disease in US clinical trials between 2000 and 2020. JAMA Netw Open 2021; 4(6): e2113749. doi: 10.1001/jamanetworkopen.2021.13749. SteinbergJR TurnerBE WeeksBT Analysis of female enrollment and participant sex by burden of disease in US clinical trials between 2000 and 2020 JAMA Netw Open 2021 4 6 e2113749 10.1001/jamanetworkopen.2021.13749 821416034143192 Open DOISearch in Google Scholar

27 Mastroianni AC, Faden R, Federman D. Executive summary. In Mastroianni AC, Faden R, Federman, D. Women and Health Research: Ethical and Legal Issues of Including Women in Clinical Studies, vol. 1. 1994. Washington (DC): National Academies Press. MastroianniAC FadenR FedermanD Executive summary In MastroianniAC FadenR FedermanD. Women and Health Research: Ethical and Legal Issues of Including Women in Clinical Studies 1 1994 Washington (DC) National Academies Press 10.1136/bmj.309.6961.1095 Search in Google Scholar

28 Sterling TR, Vlahov AJ, Astemborski J, et al. Initial plasma HIV-1 RNA levels and progression to AIDS in women and men. N Engl J Med 2001; 344: 720–725. doi: 10.1056nejm2000103083441003. SterlingTR VlahovAJ AstemborskiJ Initial plasma HIV-1 RNA levels and progression to AIDS in women and men N Engl J Med 2001 344 720 725 10.1056nejm2000103083441003 Open DOISearch in Google Scholar

29 Campaigne BMN, Wishner KL. Gender-specific health care in diabetes melitus. J Gend Specif Med 2000; 3(1): 51–58. PMID: 11253237. CampaigneBMN WishnerKL Gender-specific health care in diabetes melitus J Gend Specif Med 2000 3 1 51 58 PMID: 11253237. Search in Google Scholar

30 Walsh SJ, Rau LM. Autoimmune diseases: a leading cause of death among young and middle-aged women in the United States. Am J Public Health 2000; 90: 1463–1466. doi: 10.2105/ajph90.9.1463. WalshSJ RauLM Autoimmune diseases: a leading cause of death among young and middle-aged women in the United States Am J Public Health 2000 90 1463 1466 10.2105/ajph90.9.1463 Open DOISearch in Google Scholar

31 Thomas R, Page F, Khosia R, Vester A, Hana T, Say L. Ensuring an inclusive global health agenda for transgender people. Bull World Health Organ 2017; 95: 154–156. doi: 10.2471/blt.16.183913. ThomasR PageF KhosiaR VesterA HanaT SayL Ensuring an inclusive global health agenda for transgender people Bull World Health Organ 2017 95 154 156 10.2471/blt.16.183913 532794228250518 Open DOISearch in Google Scholar

32 Joseph A, Cliffe C, Hillyard M, Majeed A. Gender identity and the management of the transgender patient: a guide for non-specialists. J R Soc Med 2017; 110: 144–52. doi: 10.1177/0141076817696054. JosephA CliffeC HillyardM MajeedA Gender identity and the management of the transgender patient: a guide for non-specialists J R Soc Med 2017 110 144 52 10.1177/0141076817696054 540752028382847 Open DOISearch in Google Scholar

33 Valk C. A transgender person with haemophiia. J Haem Pract 2018; 5(1): 147–151. doi: 10.17225/jhp00128. ValkC A transgender person with haemophiia J Haem Pract 2018 5 1 147 151 10.17225/jhp00128 Open DOISearch in Google Scholar

34 Sanigorska A, Chaplin S, Holland M, Khair K, Pollard D. The lived experience of women with a bleeding disorder: A systematic review. Res Pract Thromb Haemost 2022; 6: e12652. doi: 10.1002/rth2.12652. SanigorskaA ChaplinS HollandM KhairK PollardD The lived experience of women with a bleeding disorder: A systematic review Res Pract Thromb Haemost 2022 6 e12652 10.1002/rth2.12652 881366335141459 Open DOISearch in Google Scholar

35 van Galen KPM, d’Oiron R, James P, et al. A new hemophilia carrier nomenclature to define hemophilia in women and girls: Communication from the SSC of the ISTH. J Thromb Haemost 2021; 19: 1883–1887. doi: 10.1111/jth.15397. van GalenKPM d’OironR JamesP A new hemophilia carrier nomenclature to define hemophilia in women and girls: Communication from the SSC of the ISTH J Thromb Haemost 2021 19 1883 1887 10.1111/jth.15397 836171334327828 Open DOISearch in Google Scholar

36 Nissen T, Wynn R. The clinical case report: a review of its merits and limitations. BMC Res Notes 2014, 7: 264. doi: 10.1186/1756-0500-7-264. NissenT WynnR The clinical case report: a review of its merits and limitations BMC Res Notes 2014 7 264 10.1186/1756-0500-7-264 400135824758689 Open DOISearch in Google Scholar

37 Carey JC. The importance of case reports in advancing scientific knowledge of rare diseases. Adv Exp Med Biol 2010; 686: 77–86. doi: 10.1007/978-90-481-9485-8_5. CareyJC The importance of case reports in advancing scientific knowledge of rare diseases Adv Exp Med Biol 2010 686 77 86 10.1007/978-90-481-9485-8_5 20824440 Open DOISearch in Google Scholar

38 Nakamura T, Igarashi H, Ito T, Jensen RT. Important of case-reports/series, in rare diseases: Using neuroendocrine tumors as an example. World J Clin Cases 2014; 2(11): 608–613. doi: 10.12998/wjcc.v2.i11.608. NakamuraT IgarashiH ItoT JensenRT Important of case-reports/series, in rare diseases: Using neuroendocrine tumors as an example World J Clin Cases 2014 2 11 608 613 10.12998/wjcc.v2.i11.608 423342425405184 Open DOISearch in Google Scholar

39 Khair K, Pollard D, Steadman L, Jenner K, Chaplin S. The views of women with bleeding disorders: Results from the Cinderella study. Haemophilia 2022;28(2): 316–325. doi: 10.1111/hae.14514. KhairK PollardD SteadmanL JennerK ChaplinS The views of women with bleeding disorders: Results from the Cinderella study Haemophilia 2022 28 2 316 325 10.1111/hae.14514 35152515 Open DOISearch in Google Scholar